JP2011068692A5 - - Google Patents

Download PDF

Info

Publication number
JP2011068692A5
JP2011068692A5 JP2011000499A JP2011000499A JP2011068692A5 JP 2011068692 A5 JP2011068692 A5 JP 2011068692A5 JP 2011000499 A JP2011000499 A JP 2011000499A JP 2011000499 A JP2011000499 A JP 2011000499A JP 2011068692 A5 JP2011068692 A5 JP 2011068692A5
Authority
JP
Japan
Prior art keywords
stomach food
day
rihaya
diisopropylaminoethyl
relaxant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011000499A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011068692A (ja
JP5360075B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2011000499A priority Critical patent/JP5360075B2/ja
Priority claimed from JP2011000499A external-priority patent/JP5360075B2/ja
Publication of JP2011068692A publication Critical patent/JP2011068692A/ja
Publication of JP2011068692A5 publication Critical patent/JP2011068692A5/ja
Application granted granted Critical
Publication of JP5360075B2 publication Critical patent/JP5360075B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2011000499A 2002-04-08 2011-01-05 胃食物受容能障害治療薬 Expired - Lifetime JP5360075B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011000499A JP5360075B2 (ja) 2002-04-08 2011-01-05 胃食物受容能障害治療薬

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002104894 2002-04-08
JP2002104894 2002-04-08
JP2011000499A JP5360075B2 (ja) 2002-04-08 2011-01-05 胃食物受容能障害治療薬

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2003581777A Division JP5281226B2 (ja) 2002-04-08 2003-04-08 胃食物受容能障害治療薬

Publications (3)

Publication Number Publication Date
JP2011068692A JP2011068692A (ja) 2011-04-07
JP2011068692A5 true JP2011068692A5 (enExample) 2012-08-09
JP5360075B2 JP5360075B2 (ja) 2013-12-04

Family

ID=28786350

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003581777A Expired - Lifetime JP5281226B2 (ja) 2002-04-08 2003-04-08 胃食物受容能障害治療薬
JP2011000499A Expired - Lifetime JP5360075B2 (ja) 2002-04-08 2011-01-05 胃食物受容能障害治療薬

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2003581777A Expired - Lifetime JP5281226B2 (ja) 2002-04-08 2003-04-08 胃食物受容能障害治療薬

Country Status (14)

Country Link
US (4) US20050176788A1 (enExample)
EP (2) EP2301540A1 (enExample)
JP (2) JP5281226B2 (enExample)
KR (4) KR20120037035A (enExample)
CN (2) CN1646123A (enExample)
AT (1) ATE522214T1 (enExample)
AU (1) AU2003236326B2 (enExample)
CA (1) CA2481916C (enExample)
CY (1) CY1112057T1 (enExample)
DK (1) DK1493441T3 (enExample)
ES (1) ES2368732T3 (enExample)
PT (1) PT1493441E (enExample)
SI (1) SI1493441T1 (enExample)
WO (1) WO2003084537A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104447612A (zh) * 2013-09-16 2015-03-25 天津市汉康医药生物技术有限公司 阿考替胺水合物晶型及其制备方法和用途
CN103980226A (zh) * 2014-05-10 2014-08-13 杭州新博思生物医药有限公司 盐酸阿考替胺水合物晶型及其制备方法
CN105315225A (zh) * 2014-07-07 2016-02-10 中美华世通生物医药科技(武汉)有限公司 阿考替胺的酸加成盐及其制备方法
CN104045606B (zh) * 2014-07-11 2015-09-30 杭州新博思生物医药有限公司 一锅法制备阿考替胺盐酸盐的方法
CN109988121B (zh) * 2019-04-28 2023-01-03 梯尔希(南京)药物研发有限公司 一种阿考替胺衍生物的制备方法
AU2022312496A1 (en) 2021-07-14 2024-02-22 Blueprint Medicines Corporation Heterocyclic compounds as map4k1 inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU699008B2 (en) * 1995-05-18 1998-11-19 Zeria Pharmaceutical Co., Ltd. Aminothiazole derivative, medicament containing the same, and intermediate for preperation of said compound
JPH10212271A (ja) 1997-01-31 1998-08-11 Zeria Pharmaceut Co Ltd N−置換ベンゾイルアミン誘導体、それを含有する医薬及び該化合物の製造中間体
PT994108E (pt) * 1997-06-24 2003-09-30 Zeria Pharm Co Ltd Processo de producao de derivados de 2-hidroxibenzamida
US5981556A (en) * 1997-07-22 1999-11-09 G.D. Searle & Co. 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors
AU770580B2 (en) * 1998-11-23 2004-02-26 Janssen Pharmaceutica N.V. Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia
AU773773B2 (en) * 1999-06-02 2004-06-03 Janssen Pharmaceutica N.V. Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
NZ518579A (en) * 1999-11-23 2003-09-26 Janssen Pharmaceutica Nv Use of 5HT3 agonists for relaxing the fundus-a cause of gastrointestinal disorder
GB0002336D0 (en) * 2000-02-01 2000-03-22 Glaxo Group Ltd Medicaments
EP1315488B1 (en) * 2000-09-08 2006-10-25 Zeria Pharmaceutical Co., Ltd. Pharmaceutical compositions containing aminothiazole derivatives for the treatment of colonic motor dysfunctions
US6986882B2 (en) * 2002-01-17 2006-01-17 Astrazeneca Ab Therapy for functional dyspepsia

Similar Documents

Publication Publication Date Title
JP2013520405A5 (enExample)
JP2011068692A5 (enExample)
JP2011037901A5 (enExample)
JP2012502885A5 (enExample)
EA201490014A1 (ru) Модифицированное высвобождение 4-метил-3-[[4-(3-пиридинил)-2-пиримидинил]амино]-n-[5-(4-метил-1h-имидазол-1-ил)-3-(трифторметил)фенил]бензамида, солюбилизированного с использованием органических кислот
JP2011201907A5 (enExample)
JP2012255026A5 (enExample)
JP2013518107A5 (enExample)
JP2013534248A5 (enExample)
JP2012184234A5 (enExample)
JP2015515475A5 (enExample)
JP2014515013A5 (enExample)
JP2010536849A5 (enExample)
JP2009537554A5 (enExample)
HRP20161577T1 (hr) Inhibitori replikacije virusa gripe
JP2012502037A5 (enExample)
JP2012533546A5 (enExample)
JP2014505107A5 (enExample)
IL292465B2 (en) Neuroactive compounds and methods of use thereof
JP2011219478A5 (enExample)
JP2014503593A5 (enExample)
WO2013057251A3 (en) Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
WO2012090225A3 (en) Novel cocrystals / molecular salts of metformin with oleoylethanolamide as an effective anti-diabetic + anti- obesity agent
JP2018531273A5 (enExample)
JP2012501334A5 (enExample)